Nongenomic response to aldosterone

Hypertension

Volumn 58, Issue 2, 2011, Pages

  Osanai, Tomohiro ^a   Yamada, Masahiro ^a   Okumura, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ALDOSTERONE; ANGIOTENSIN 1A RECEPTOR; CANDESARTAN; CYSTAMINE; DANSYLCADAVERINE; EPLERENONE; G PROTEIN COUPLED RECEPTOR 30; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN; SPIRONOLACTONE; VALSARTAN;

AORTA; ARTERIOLE; BLOOD VESSEL DIAMETER; DOSE RESPONSE; ENZYME ACTIVATION; HORMONE RESPONSE; IN VITRO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ALDOSTERONE; ANIMALS; MESENTERIC ARTERIES; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 80051472794     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.174680     Document Type: Letter

References (2)

1. Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J, Feldman RD. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension. 2011;57:442-451.
2. Yamada M, Kushibiki M, Osanai T, Tomita H, Okumura K. Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: Possible role of AT1 receptor dimerization. Cardiovasc Res. 2008;79: 169-178. (Pubitemid 351881932)